Medarex, Inc. Issues Notice of Change in Control to Holders of its Convertible Notes

Published: Sep 24, 2009

NEW YORK--(BUSINESS WIRE)--Medarex, Inc., a wholly owned subsidiary of Bristol-Myers Squibb Company (NYSE: BMY), issued, under the terms of the indenture for Medarex’s 2.25% Convertible Senior Notes due May 15, 2011 (the “Convertible Notes”), a notice of change in control (the “Company Notice”) to holders of the Convertible Notes.

Back to news